Phospho-Histone H2A.X (S139) Recombinant Rabbit Monoclonal Antibody [SR33-09]
Usd: 205 Special Discount
Specification
Catalog# ET1602-2
Phospho-Histone H2A.X (S139) Recombinant Rabbit Monoclonal Antibody [SR33-09]
-
WB
-
IHC-P
-
IF-Cell
-
IF-Tissue
-
Human
-
Mouse
-
Rat
-
Cynomolgus monkey
-
HA750034
不含抗保成分
-
unconjugated
Safety datasheet
Overview
Product Name
Phospho-Histone H2A.X (S139) Recombinant Rabbit Monoclonal Antibody [SR33-09]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic phospho-peptide corresponding to residues surrounding Ser139 of Human Histone H2AX.
Species Reactivity
Human, Mouse, Rat, Cynomolgus monkey
Validated Applications
WB, IHC-P, IF-Cell, IF-Tissue
Molecular Weight
Predicted band size: 15 kDa
Positive Control
NIH/3T3 cell lysate, NIH/3T3 treated with 25μM Etoposide for 5 hours cell lysate, HeLa treated with 20μM Etoposide for 2 hours whole cell lysate, HeLa treated with UV for 2 hours whole cell lysate, C6 treated with 25μM Etoposide for 5 hours whole cell lysate, rat brain tissue, mouse testis tissue, mouse small intestine tissue, human colon carcinoma tissue, human colon cancer tissue, mouse breast tissue, mouse skin tissue, HeLa cells treated with 20μM etoposide for 2 hours.
Conjugation
unconjugated
Clone Number
SR33-09
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000-1:5,000
-
IHC-P
-
1:500-1:5,000
-
IF-Cell
-
1:2,000-1:3,000
-
IF-Tissue
-
1:500
Target
Function
Histone H2A.X is a member of the Histone H2A family, which is involved in nucleosomal organization of chromatin. An important phosphorylated form is γH2AX (S139), which forms when double-strand breaks appear. In humans and other eukaryotes, the DNA is wrapped around histone octamers, consisting of core histones H2A, H2B, H3 and H4, to form chromatin. H2AX contributes to nucleosome-formation, chromatin-remodeling and DNA repair, and is also used in vitro as an assay for double-strand breaks in dsDNA.
Background References
1. Kung, M.L. et al. 2015. Enhanced reactive oxygen species overexpression by CuO nanoparticles in poorly differentiated hepatocellular carcinoma cells. Nanoscale. 7: 1820-9.
2. Cilli, D. et al. 2014. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation. PloS one. 9: e114651.
Sequence Similarity
Belongs to the histone H2A family.
Post-translational Modification
Phosphorylated on Ser-140 (to form gamma-H2AX or H2AX139ph) in response to DNA double strand breaks (DSBs) generated by exogenous genotoxic agents and by stalled replication forks, and may also occur during meiotic recombination events and immunoglobulin class switching in lymphocytes. Phosphorylation can extend up to several thousand nucleosomes from the actual site of the DSB and may mark the surrounding chromatin for recruitment of proteins required for DNA damage signaling and repair. Widespread phosphorylation may also serve to amplify the damage signal or aid repair of persistent lesions. Phosphorylation of Ser-140 (H2AX139ph) in response to ionizing radiation is mediated by both ATM and PRKDC while defects in DNA replication induce Ser-140 phosphorylation (H2AX139ph) subsequent to activation of ATR and PRKDC. Dephosphorylation of Ser-140 by PP2A is required for DNA DSB repair. In meiosis, Ser-140 phosphorylation (H2AX139ph) may occur at synaptonemal complexes during leptotene as an ATM-dependent response to the formation of programmed DSBs by SPO11. Ser-140 phosphorylation (H2AX139ph) may subsequently occurs at unsynapsed regions of both autosomes and the XY bivalent during zygotene, downstream of ATR and BRCA1 activation. Ser-140 phosphorylation (H2AX139ph) may also be required for transcriptional repression of unsynapsed chromatin and meiotic sex chromosome inactivation (MSCI), whereby the X and Y chromosomes condense in pachytene to form the heterochromatic XY-body. During immunoglobulin class switch recombination in lymphocytes, Ser-140 phosphorylation (H2AX139ph) may occur at sites of DNA-recombination subsequent to activation of the activation-induced cytidine deaminase AICDA. Phosphorylation at Tyr-143 (H2AXY142ph) by BAZ1B/WSTF determines the relative recruitment of either DNA repair or pro-apoptotic factors. Phosphorylation at Tyr-143 (H2AXY142ph) favors the recruitment of APBB1/FE65 and pro-apoptosis factors such as MAPK8/JNK1, triggering apoptosis. In contrast, dephosphorylation of Tyr-143 by EYA proteins (EYA1, EYA2, EYA3 or EYA4) favors the recruitment of MDC1-containing DNA repair complexes to the tail of phosphorylated Ser-140 (H2AX139ph).; Monoubiquitination of Lys-120 (H2AXK119ub) by RING1 and RNF2/RING2 complex gives a specific tag for epigenetic transcriptional repression (By similarity). Following DNA double-strand breaks (DSBs), it is ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2 ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the recruitment of repair proteins to sites of DNA damage. Ubiquitination at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response to DNA damage is initiated by RNF168 that mediates monoubiquitination at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains in vitro. H2AK119Ub and ionizing radiation-induced 'Lys-63'-linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.; Acetylation at Lys-37 increases in S and G2 phases. This modification has been proposed to play a role in DNA double-strand break repair (By similarity).
Subcellular Location
Nucleus, Chromosome
Synonyms
AW228881 antibody
H2A histone family member X antibody
H2A.FX antibody
H2A.X antibody
H2a/x antibody
H2AFX antibody
H2AX antibody
H2AX histone antibody
H2AX_HUMAN antibody
Hist5.2ax antibody
ExpandAW228881 antibody
H2A histone family member X antibody
H2A.FX antibody
H2A.X antibody
H2a/x antibody
H2AFX antibody
H2AX antibody
H2AX histone antibody
H2AX_HUMAN antibody
Hist5.2ax antibody
Histone 2A antibody
Histone 2AX antibody
Histone H2A.X antibody
Histone H2AX antibody
RGD1566119 antibody
gamma H2A.X antibody
γ H2A.X antibody
γ-H2A.X antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of Phospho-Histone H2A.X (S139) on different lysates with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/5,000 dilution.
Lane 1: NIH/3T3 cell lysate (20 µg/Lane)
Lane 2: NIH/3T3 treated with 25μM Etoposide for 5 hours cell lysate (20 µg/Lane)
Predicted band size: 15 kDa
Observed band size: 15 kDa
Exposure time: 6 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1602-2) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Western blot analysis of Phospho-Histone H2A.X (S139) on different lysates with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/2,000 dilution.
Lane 1: HeLa whole cell lysate
Lane 2: HeLa treated with 20μM Etoposide for 2 hours whole cell lysate
Lane 3: HeLa whole cell lysate
Lane 4: HeLa treated with UV for 2 hours whole cell lysate
Lane 5: NIH/3T3 whole cell lysate
Lane 6: NIH/3T3 treated with 25μM Etoposide for 5 hours whole cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 15 kDa
Observed band size: 15/20 kDa
Exposure time: 53 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1602-2) at 1/2,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/100,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Western blot analysis of Phospho-Histone H2A.X (S139) on different lysates with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/2,000 dilution.
Lane 1: C6 treated with 25μM Etoposide for 5 hours whole cell lysate
Lane 2: C6 whole cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 15 kDa
Observed band size: 15 kDa
Exposure time: 20 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1602-2) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded rat brain tissue with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1602-2) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse testis tissue with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1602-2) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse small intestine tissue with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1602-2) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1602-2) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human colon cancer tissue with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1602-2) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse breast tissue with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1602-2) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse skin tissue with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1602-2) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of HeLa cells untreated / treated with 20μM etoposide for 2 hours labeling Phospho-Histone H2A.X (S139) with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/2,000 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/2,000 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of 4T1 cells labeling Phospho-Histone H2A.X (S139) with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/3,000 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-Histone H2A.X (S139) antibody (ET1602-2) at 1/3,000 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Application: IF-tissue
Species: Cynomolgus monkey
Site: Lung
Sample: Paraffin-embedded section
Antibody concentration: 1/500
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
The role of AKR1C3 in regulating chondrocyte aging in knee osteoarthritis
Journal: Journal Of Radiation Research And Applied Sciences
DOI: 10.1016/j.jrras.2026.102272
IF: 2.5
Application: IHC
Reactivity: Rat
Publish date: 2026 Mar
-
Potential of RAD51C as a hub gene and therapeutic target in bladder cancer: insights from bioinformatics and experimental analysis
Journal: International Journal of Surgery
DOI: 10.1097/JS9.0000000000005112
IF: 10.1
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
Chemotherapy-induced senescent nasopharyngeal carcinoma cells suppress NK cell-mediated antitumor immunity by upregulating EBI3 via mtDNA-cGAS-STING pathway
Journal: Cell Communication And Signaling
DOI: 10.1186/s12964-026-02848-6
IF: 8.9
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
BMAL1 silencing as a promising chemosensitizing strategy for triple-negative breast cancer
Journal: Acta Pharmacologica Sinica
DOI: 10.1038/s41401-026-01788-8
IF: 8.4
Application: IHC
Reactivity: Mouse
Publish date: 2026 Mar
-
Preclinical Study of CDH3-Targeted 89Zr/177Lu Theranostics in Triple-Negative Breast Cancer
Journal: Molecular Pharmaceutics
DOI: 10.1021/acs.molpharmaceut.5c01584
IF: 4.5
Application: IF-tissue
Reactivity: Mouse
Publish date: 2026 Jan
-
A halogenated pregnenolone analogue suppresses HepG2 proliferation and induces apoptosis via PPARγ regulation
Journal: RSC Medicinal Chemistry
DOI: 10.1039/D5MD01142F
IF: 3.6
Application: IF-cell
Reactivity: Human
Publish date: 2026 Feb
-
Targeted Blockage of Pathological Extracellular Vesicles and Particles From Fibroblast-Like Synoviocytes for Osteoarthritis Relief: Proteomic Analysis and Cellular Effect
Journal: Journal Of Extracellular Vesicles
DOI: 10.1002/jev2.70162
IF: 14.5
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
MTFR2-Mediated Fission Drives Fatty Acid and Mitochondrial Co-Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis
Journal: Advanced Science
DOI: 10.1002/advs.202416419
IF: 14.3
Application: IF-cell
Reactivity: Human
Publish date: 2025 May
-
CD38 inhibits ferroptosis to promote radiotherapy resistance in nasopharyngeal carcinoma by competitively binding to TRIM21 to stabilize SLC7A11 protein
Journal: International Journal Of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2025.144742
IF: 7.7
Application: WB
Reactivity: Human
Publish date: 2025 May
-
Harnessing the power of traceable system C-GAP: homologous-targeting to fire up T-cell immune responses with low-dose irradiation
Journal: Journal Of Nanobiotechnology
DOI: 10.1186/s12951-025-03281-6
IF: 10.6
Application: IHC-P
Reactivity: Mouse
Publish date: 2025 Mar
-
MMAE-Based Peptide–Drug Conjugates Targeting GPC3 for Precision Chemoradiotherapy in Hepatocellular Carcinoma
Journal: Journal Of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.5c00847
IF: 6.8
Application: IF-cell
Reactivity: Mouse,Human
Publish date: 2025 Jun
-
Topoisomerase I Inhibition in ETV4-overexpressed Non-Small Cell Lung Cancer Promotes Replication and Transcription Mediated R-Loop Accumulation and DNA Damage
Journal: Advanced Science
DOI: 10.1002/advs.202409307
IF: 14.1
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Morphology– and adhesion–dual biomimetic nanovaccine boosts antigen cross-presentation through subcellular transport regulation
Journal: Science Advances
DOI: 10.1126/sciadv.adx6732
IF: 12.5
Application: IF-tissue
Reactivity: Mouse
Publish date: 2025 Jul
-
Programmable Biporphyrin-G-Quadruplex Nanoflowers for Simultaneous Tumor Cell Recognition and Enhanced Photodynamic Therapy
Journal: Small Methods
DOI: 10.1002/smtd.202401993
IF: 9.1
Application: IF-cell
Reactivity: Human
Publish date: 2025 Jul
-
Targeting ribosomes reprograms the tumour microenvironment and augments cancer immunotherapy
Journal: British Journal of Cancer
DOI: 10.1038/s41416-025-03109-y
IF: 6.8
Application: IF-cell
Reactivity: Mouse
Publish date: 2025 Jul
-
Protocatechuic aldehyde sensitizes BRAF-mutant melanoma cells to temozolomide through inducing FANCD2 degradation
Journal: MEDICAL ONCOLOGY
DOI: 10.1007/s12032-025-02601-y
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Down-regulation of PCK2 enhanced the radioresistance phenotype of nasopharyngeal carcinoma
Journal: International Journal Of Radiation Biology
DOI: 10.1080/09553002.2025.2470226
IF: 2.1
Application: IF-cell
Reactivity: Human
Publish date: 2025 Feb
-
The SUMOylated RREB1 interacts with KDM1A to induce 5-fluorouracil resistance via upregulating thymidylate synthase and activating DNA damage response pathway in colorectal cancer
Journal: Medicine And Communication
DOI: 10.1002/mco2.70105
IF: 10.7
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
HDAC2-Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple-Negative Breast Cancer
Journal: Advanced Science
DOI: 10.1002/advs.202413121
IF: 14.3
Application: IF-cell
Reactivity: Mouse,Human
Publish date: 2025 Feb
-
ERRγ Promotes Multiple Myeloma Survival by Coordinating NF-κB Signaling and Mitochondrial Apoptosis Regulation
Journal: Oncology Research
DOI: 10.32604/or.2025.063700
IF: 4.1
Application: WB
Reactivity: Human
Publish date: 2025 Aug
-
Tanshinone IIA is synergistic with the PARP inhibitor olaparib in inducing BRCAs-proficient and -deficient triple-negative breast cancer cell apoptosis
Journal: Medical Oncology
DOI: 10.1007/s12032-025-02968-y
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2025 Aug
-
Small molecular chelator for comprehensive regulation of tumor lactate levels in synergy with photodynamic therapy for cancer treatment
Journal: Asian Journal of Pharmaceutical Sciences
DOI: 10.1016/j.ajps.2025.101059
IF: 10.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Apr
-
Evaluated NSUN3 in reticulocytes from HbH-CS disease that reflects cellular stress in erythroblasts
Journal: Annals of Hematology
DOI: 10.1007/s00277-025-06359-1
IF: 3
Application: WB
Reactivity: Human
Publish date: 2025 Apr
-
Schisandrin C prevents Regorafenib-Induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes
Journal: Toxicological Sciences
DOI: 10.1093/toxsci/kfae127
IF: 3.4
Application: IF-cell
Reactivity: Human,Rat
Publish date: 2024 Sept
-
Deficiency of TET2-mediated KMT2D self-transcription confers a targetable vulnerability in hepatocellular carcinoma
Journal: Proceedings Of The National Academy Of Sciences Of The United States Of America
DOI:
IF: 2.2
Application: WB
Reactivity: Human
Publish date: 2024 Nov
-
Molecular Regulatory Mechanism of Nano-Se Against Copper-Induced Spermatogenesis Disorder
Journal: Biological Trace Element Research
DOI:
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2024 Mar
-
Mitophagy defect mediates the aging-associated hallmarks in Hutchinson-Gilford progeria syndrom
Journal: Aging Cell
DOI:
IF: 8
Application: WB
Reactivity: Human
Publish date: 2024 Jun
-
Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells
Journal: Annals Of Hematology
DOI:
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2024 Jan
-
The crucial involvement of gamma-Mangostin and CYP1B1 in the mechanism underlying the toxicity caused by cigarette smoke extract: In silico and in vitro insights
Journal: Toxicology
DOI:
IF: 4.8
Application: WB
Reactivity: Human
Publish date: 2024 Dec
-
Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway
Journal: International Journal Of Biological Sciences
DOI:
IF: 8.2
Application: WB
Reactivity: Mouse
Publish date: 2024 Aug
-
Pterostilbene, a Resveratrol Derivative, Improves Ovary Function by Upregulating Antioxidant Defenses in the Aging Chickens via Increased SIRT1/Nrf2 Expression
Journal: Antioxidants
DOI:
IF: 6
Application: WB
Reactivity: Chicken
Publish date: 2024 Aug
-
Costunolide ameliorates MNNG-induced chronic atrophic gastritis through inhibiting oxidative stress and DNA damage via activation of Nrf2
Journal: Phytomedicine
DOI:
IF: 7.9
Application: WB
Reactivity: Human
Publish date: 2024 Apr
-
CFAP58 is involved in the sperm head shaping and flagellogenesis of cattle and mice
Journal: Development
DOI: 10.1242/dev.202608
IF: 3.7
Application: WB
Reactivity: Mouse
Publish date: 2024 Apr
-
Genotoxicity of bisphenol AF in rats: Detrimental to male reproductive system and probable stronger micronucleus induction potency than BPA
Journal: Journal Of Applied Toxicology
DOI:
IF: 3.3
Application: IHC-P
Reactivity: Rat
Publish date: 2023 Oct
-
Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing deoxyribonucleic acid (DNA) damage-dependent cell cycle arrest
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2023.155177
IF: 7.9
Application:
Reactivity:
Publish date: 2023 Nov
-
TPP1 inhibits DNA damage response and chemosensitivity in esophageal cancer
Journal: Critical Reviews In Eukaryotic Gene Expression
DOI:
IF: 1.6
Application: WB
Reactivity: Human
Publish date: 2023 May
-
Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL
Journal: Advanced Science
DOI:
IF: 15.1
Application: WB
Reactivity: Mouse
Publish date: 2023 Jul
-
ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade
Journal: Nature Communications
DOI:
IF: 16.6
Application: WB
Reactivity: Human
Publish date: 2023 Jul
-
Dasatinib causes keratinocyte apoptosis via inhibiting high mobility group Box 1-mediated mitophagy
Journal: Toxicology Letters
DOI:
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2023 Jan
-
miR-653-3p promotes genomic instability of colorectal cancer cells via targeting SIRT1/TWIST1 signaling pathway
Journal: Biochimica Et Biophysica Acta-Molecular Basis Of Disease
DOI:
IF: 6.2
Application: WB
Reactivity: Mouse
Publish date: 2023 Dec
-
Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells
Journal: BMC Complementary Medicine and Therapies
DOI:
IF: 2.838
Application: WB
Reactivity: Human
Publish date: 2023 Apr
-
A novel and potent dihydroorotate dehydrogenase inhibitor suppresses the proliferation of colorectal cancer by inducing mitochondrial dysfunction and DNA damage
Journal: Medcomm-Oncology
DOI:
IF: NA
Application: WB
Reactivity: Human
Publish date: 2022 Jul
-
An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety
Journal: Nanoscale Advances
DOI:
IF: 5.110
Application: IHC-P
Reactivity: Mouse
Publish date: 2022 Feb
-
Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition
Journal: Molecular Carcinogenesis
DOI: 10.1002/mc.22795
IF: 3.851
Application: WB
Reactivity: Human
Publish date: 2018 Mar